Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression changes in breast cancer cells upon USP1 knockdown [RNA-Seq]

ABSTRACT: Gene expression changes in breast cancer cells upon USP1 knockdown [RNA-Seq]

PROVIDER: PRJNA438337 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6834781_1.fastq.gz	Fastqsanger.gz
	SRR6834781_2.fastq.gz	Fastqsanger.gz
	SRR6834782_1.fastq.gz	Fastqsanger.gz
	SRR6834782_2.fastq.gz	Fastqsanger.gz
	SRR6834783_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Gene expression changes in breast cancer cells upon USP1 knockdown [RNA-Seq]

Project description:To explore the function of deubiquitinase USP1 in breast cancer cells, we performed RNA sequencing to analyze the expression pattern changes by knockdown of USP1 in MCF7 cells.

2021-03-14 | GSE111838 | GEO

Transcriptome changes upon Cas13-based knockdown

Project description:Transcriptome changes upon Cas13-based knockdown

| PRJNA648763 | ENA

Transcriptomics changes upon WNK1 knockdown in JJN3 cells

Project description:Transcriptomics changes upon WNK1 knockdown in JJN3 cells

| PRJNA1024367 | ENA

USP1 identified as an important factor in the progression of gastric cancer

Project description:Gastric cancer is one of the leading causes of cancer-related deaths, and through in vivo and in vitro genetic screens, we identified USP1 as an important factor in promoting tumor progression. Here, we analyzed the transcriptome of sh-USP after knockdown with the aim of identifying downstream effectors of USP1

2024-12-01 | GSE282776 | GEO

USP1 expression driven by EWS-FLI1 transcription factor stabilizes Survivin and promotes Ewing sarcoma cell survival

Project description:Ewing sarcoma (EWS) is a malignant pediatric bone cancer. Most Ewing sarcomas are driven by EWS-FLI1 oncogenic transcription factor that plays roles in transcriptional regulation, DNA damage response, cell cycle checkpoint control, and alternative splicing. USP1, a deubiquitylase which regulates DNA damage and replication stress responses, is overexpressed at both the mRNA and protein levels in EWS cell lines compared to human mesenchymal stem cells, the EWS cell of origin. The functional significance of high USP1 expression in Ewing sarcoma is not known. Here, we identify USP1 as a transcriptional target of EWS-FLI1 and a key regulator of EWS cell survival. We show that EWS-FLI1 knockdown decreases USP1 mRNA and protein levels. ChIP and ChIP-seq analyses show EWS-FLI1 occupancy on the USP1 promoter. Importantly, USP1 knockdown or inhibition arrests EWS cell growth and induces cell death by apoptosis. We observe destabilization of Survivin (also known as BIRC5 or IAP4) and activation of caspases-3 and -7 following USP1 knockdown or inhibition in the absence of external DNA damage stimuli. Notably, EWS cells display hypersensitivity to combinatorial treatment of doxorubicin or etoposide, EWS standard of care drugs, and USP1 inhibitor compared to single agents alone. Together, our study demonstrates that USP1 is regulated by EWS-FLI1, the USP1-Survivin axis promotes EWS cell survival, and USP1 inhibition sensitizes EWS cells to standard of care chemotherapy.

2024-01-26 | PXD041033 | Pride

Gene expression changes in lung cancer cells upon TIGD1 knockdown

Project description:Gene expression changes in lung cancer cells upon TIGD1 knockdown

| PRJNA953661 | ENA

Ubiquitinated PCNA drives USP1 synthetic lethality in cancer

Project description:CRISPR Cas9-based functional genomics screening is a powerful approach for identifying and characterizing novel oncology drug targets. Here, we elucidate the synthetic lethal mechanism of deubiquitinating enzyme USP1 in cancers with underlying DNA damage vulnerabilities, specifically BRCA1/2 mutant tumors and a subset of BRCA1/2 wild-type (WT) tumors. In sensitive cells, pharmacological inhibition of USP1 leads to decreased DNA synthesis concomitant with the induction of S-phase-specific DNA damage. Genome-wide CRISPR-Cas9 screens identified RAD18 and UBE2K, which promote PCNA mono- and polyubiquitination respectively, as downstream mediators of USP1 dependency. The accumulation of mono- and polyubiquitinated PCNA following USP1 inhibition was associated with a reduction in total PCNA protein levels. Ectopic expression of WT and ubiquitin-dead K164R PCNA reversed USP1 inhibitor sensitivity. Our results demonstrate, for the first time, that USP1 dependency hinges on the aberrant processing of mono- and polyubiquitinated PCNA. Moreover, this mechanism of USP1 dependency extends beyond BRCA1/2 mutant tumors to a novel subset of BRCA1/2 WT cancer enriched in ovarian and lung lineages. We further show PARP and USP1 inhibition are strongly synergistic in BRCA1/2 mutant cell lines and xenograft models. We postulate USP1 dependency unveils a previously uncharacterized vulnerability linked to post-translational modifications of PCNA. Taken together, USP1 inhibition may represent a unique therapeutic strategy for BRCA1/2 mutant tumors and a subset of BRCA1/2 WT tumors.

2022-09-27 | GSE214121 | GEO

Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown

Project description:Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown

| PRJNA421947 | ENA

Gene expression changes in stage 23 Xenopus laevis embryos upon Neil2 knockdown

Project description:Gene expression changes in stage 23 Xenopus laevis embryos upon Neil2 knockdown

| PRJNA533805 | ENA

USP1 modulates hepatocellular carcinoma progression via Hippo/TAZ axis

Project description:To investigate the function of USP1 in the HCC.

2022-11-23 | GSE218366 | GEO